Published in Int J Sport Nutr Exerc Metab on December 01, 2009
Exercise as a mediator of hepcidin activity in athletes. Eur J Appl Physiol (2010) 0.99
The effects of carbohydrate ingestion during endurance running on post-exercise inflammation and hepcidin levels. Eur J Appl Physiol (2011) 0.98
Iron status and the acute post-exercise hepcidin response in athletes. PLoS One (2014) 0.96
A seven day running training period increases basal urinary hepcidin levels as compared to cycling. J Int Soc Sports Nutr (2014) 0.81
Timing of post-exercise carbohydrate ingestion: influence on IL-6 and hepcidin responses. Eur J Appl Physiol (2015) 0.80
Acute dietary carbohydrate manipulation and the subsequent inflammatory and hepcidin responses to exercise. Eur J Appl Physiol (2015) 0.80
Hepcidin and sports anemia. Cell Biosci (2014) 0.80
Influence of post-exercise hypoxic exposure on hepcidin response in athletes. Eur J Appl Physiol (2014) 0.78
Exercise-induced changes in iron status and hepcidin response in female runners. PLoS One (2013) 0.77
Acute hypoxic exercise does not alter post-exercise iron metabolism in moderately trained endurance athletes. Eur J Appl Physiol (2014) 0.77
Nutritional implications for ultra-endurance walking and running events. Extrem Physiol Med (2016) 0.75
Elevated Serum Hepcidin Levels during an Intensified Training Period in Well-Trained Female Long-Distance Runners. Nutrients (2017) 0.75
Elevated hepcidin serum level in response to inflammatory and iron signals in exercising athletes is independent of moderate supplementation with vitamin C and E. Physiol Rep (2015) 0.75
Hematological and biochemical markers of iron status in a male, young, physically active population. Biomed Res Int (2014) 0.75
Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis. PLoS One (2016) 0.75
Seven days of high carbohydrate ingestion does not attenuate post-exercise IL-6 and hepcidin levels. Eur J Appl Physiol (2016) 0.75
Factors influencing the post-exercise hepcidin-25 response in elite athletes. Eur J Appl Physiol (2017) 0.75
Post-exercise serum hepcidin levels were unaffected by hypoxic exposure during prolonged exercise sessions. PLoS One (2017) 0.75
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet (2007) 19.18
Many sequence variants affecting diversity of adult human height. Nat Genet (2008) 12.80
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet (2007) 12.65
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2007) 10.81
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2008) 7.65
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest (2005) 4.84
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res (2002) 3.78
Randomised controlled trial of graded exercise in chronic fatigue syndrome. Med J Aust (2004) 3.42
Hepcidin: from discovery to differential diagnosis. Haematologica (2008) 2.69
Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer (2006) 2.50
Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem (2007) 2.41
Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum (2011) 2.38
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest (2011) 2.36
Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis (2011) 2.05
Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res (2011) 1.83
Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79
Physiological and metabolic responses of repeated-sprint activities:specific to field-based team sports. Sports Med (2005) 1.78
Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis (2011) 1.74
Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Hum Mutat (2002) 1.70
Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem (2010) 1.68
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol (2010) 1.66
Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis (2009) 1.63
Physiology of small-sided games training in football: a systematic review. Sports Med (2011) 1.59
Beneficial effects of ice ingestion as a precooling strategy on 40-km cycling time-trial performance. Int J Sports Physiol Perform (2010) 1.54
Hepatic iron loading in mice increases cholesterol biosynthesis. Hepatology (2010) 1.53
Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol Dis (2007) 1.51
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Hepcidin in human iron disorders: diagnostic implications. Clin Chem (2011) 1.50
Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem (2005) 1.48
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. Leuk Lymphoma (2013) 1.47
Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica (2010) 1.47
Thermoregulatory responses in post-coronary artery bypass surgery and healthy males during moderate exercise in warm and cool environments. J Cardiopulm Rehabil (2002) 1.45
Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study. J Gerontol A Biol Sci Med Sci (2010) 1.45
Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood (2008) 1.43
Combined aerobic and resistance exercise improves glycemic control and fitness in type 2 diabetes. Diabetes Res Clin Pract (2002) 1.42
Hereditary haemochromatosis: to screen or not to screen? J Hepatol (2005) 1.38
Observation and prediction of recurrent human translocations mediated by NAHR between nonhomologous chromosomes. Genome Res (2011) 1.37
Exercise prescription for individuals with chronic fatigue syndrome. Med J Aust (2005) 1.35
(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem (2009) 1.30
Osteosclerosis owing to Notch gain of function is solely Rbpj-dependent. J Bone Miner Res (2010) 1.25
Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant (2009) 1.22
Effect of hydrotherapy on the signs and symptoms of delayed onset muscle soreness. Eur J Appl Physiol (2007) 1.22
The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci (2007) 1.21
Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones. Eur J Appl Physiol (2008) 1.21
Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. Hum Mol Genet (2005) 1.19
Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol (2008) 1.19
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol (2009) 1.19
Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab (2009) 1.18
The influence of pacing strategy on VO2 and supramaximal kayak performance. Med Sci Sports Exerc (2002) 1.17
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform. Anal Biochem (2005) 1.16
CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet (2012) 1.16
Induced metabolic alkalosis affects muscle metabolism and repeated-sprint ability. Med Sci Sports Exerc (2004) 1.16
Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis. Blood (2004) 1.15
The effects of training intensity on muscle buffer capacity in females. Eur J Appl Physiol (2005) 1.15
Proteoglycan 4 expression protects against the development of osteoarthritis. Sci Transl Med (2013) 1.14
Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface. PLoS One (2012) 1.12
Activity profiles and physical demands of elite women's water polo match play. J Sports Sci (2009) 1.10
Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol (2003) 1.09
Shedding & shaving: disclosure of proteomic expressions on a bacterial face. Proteomics (2008) 1.09
Influence of cold water immersion on limb and cutaneous blood flow at rest. Am J Sports Med (2011) 1.09
Time-motion analysis of elite field hockey, with special reference to repeated-sprint activity. J Sports Sci (2004) 1.08
Quantitative imaging of murine osteoarthritic cartilage by phase-contrast micro-computed tomography. Arthritis Rheum (2013) 1.08
Liver iron transport. World J Gastroenterol (2007) 1.08
Muscle buffer capacity and aerobic fitness are associated with repeated-sprint ability in women. Eur J Appl Physiol (2004) 1.07
An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One (2008) 1.06
Validity and reliability of GPS units to monitor cricket-specific movement patterns. Int J Sports Physiol Perform (2009) 1.06
The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis. J Clin Endocrinol Metab (2009) 1.06
Effects of caffeine on prolonged intermittent-sprint ability in team-sport athletes. Med Sci Sports Exerc (2006) 1.05
A novel immunological assay for hepcidin quantification in human serum. PLoS One (2009) 1.05
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler Thromb Vasc Biol (2010) 1.05
Effects of chronic NaHCO3 ingestion during interval training on changes to muscle buffer capacity, metabolism, and short-term endurance performance. J Appl Physiol (1985) (2006) 1.04
Training surface and intensity: inflammation, hemolysis, and hepcidin expression. Med Sci Sports Exerc (2009) 1.04
Cumulative effects of consecutive running sessions on hemolysis, inflammation and hepcidin activity. Eur J Appl Physiol (2009) 1.03
Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr (2009) 1.02
Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts. Am J Obstet Gynecol (2003) 1.01
Effects of high- and moderate-intensity training on metabolism and repeated sprints. Med Sci Sports Exerc (2005) 1.00
Mass spectrometry analysis of hepcidin peptides in experimental mouse models. PLoS One (2011) 1.00
High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin. Transfusion (2012) 1.00
Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients. Acta Haematol (2009) 0.99